News & Insights
Find up-to-date information and news regarding important policy and industry updates affecting the long-term care pharmacy community. This page is updated regularly to include new research and federal policy impacts on this community.
Press Releases & Statements
As the only national organization exclusively representing the interests of LTC pharmacies, hear directly from SCPC.
Releases & Statements
05/05/2022
Bring it on home: Obstacles and opportunities in bringing long-term care pharmacy services to Medicare beneficiaries living at home
By Alan Rosenbloom As anyone who has been prescribed medication knows, pharmacies play a crucial role in our health care system. This is especially true for older people, since their reliance on medications to treat their overall health care needs increases. While younger, healthier people can turn to a local retail pharmacist, people with medically […]
Read MoreReleases & Statements
04/14/2022
Health Equity and Access to LTC Pharmacy Services
Limited community access to LTC pharmacy services has implications for achieving health equity in LTC. The confluence of needs for long-term care and chronic health care services among Medicare beneficiaries who need LTC should be central to policy making. Congress and CMS should craft integrated policies that address chronic health care and LTC needs for individuals living in the community, and medication management should be central to such efforts.
Read MoreReleases & Statements
03/07/2022
SCPC Provides Comments on CMS Proposed Rule Regarding Medicare Program
Dear Administrator Brooks-LaSure: The Senior Care Pharmacy Coalition (SCPC) appreciates the opportunity to comment on the CMS Proposed Rule entitled “Medicare Program: Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefits Programs;” Agency Docket Number CMS-4192-P (the Proposed Rule).1 SCPC is the only Washington-based organization exclusively representing the […]
Read MoreIn The News
Recent coverage of SCPC in the news.
In the News
05/03/2022
Free market is at risk because of PBM titans’ anti-competitive behaviors
Congress must thoroughly investigate the anti-competitive behaviors of these conglomerates and act accordingly. Doing so will provide better outcomes both for patients and a more competitive marketplace for unaffiliated pharmacies. By Alan Rosenbloom We’ve been here before, right? A Congress and Administration eager to talk about mysterious escalating prescription drug prices. Over the years, both […]
Read MoreIn the News
02/18/2022
Senior-Care Pharmacies Oppose Pharmacy Concession Proposal
By John Wilkerson, Inside Health Policy Contrary to independent retail pharmacies, long-term care pharmacies oppose CMS’ proposal to make Part D plans give concessions they receive from network pharmacies to beneficiaries at the point of sale. Senior Care Pharmacy Coalition President and CEO Alan Rosenbloom said the proposed policy would legitimize what he called illegitimate […]
Read MoreIn the News
02/01/2022
Don’t overlook management of medications in infection battle
By John Hall McKnight’s Long Term Care News Many once-waning yet still-debilitating infections are rising in numbers again, erasing some of the gains made fighting multidrug resistant organisms. Because nursing home staff were so focused on a vertical approach toward fighting the pandemic, epidemiologists are reporting increases in infections such as MRSA and Candida auris, […]
Read MoreOur Videos
SCPC welcomes the opportunity to highlight the work of the LTC pharmacy community. To learn more about the LTC pharmacy sector, click the link below and watch the videos highlighting the important, unique work our members do in their communities.
Policy & Sector Insights
The LTC pharmacy sector is in constant change with new research, policies and news.
Policy & Sector Insights
01/07/2022
Prescription Drug Policy, 2021 And 2022: The Year In Review, And The Year Ahead
By Rachel Sachs Health Affairs This past year was filled with news in the prescription drug policy area, from the Food and Drug Administration’s (FDA) most controversial drug approval in many years to ongoing discussions in Congress over drug pricing reform. Through it all, the importance of responding to the COVID-19 pandemic has remained at […]
Read MorePolicy & Sector Insights
12/16/2021
Why the big questions about drug prices are rarely asked: It’s hard to do
By Fred D. Ledley STAT News Public debate over legislation to allow Medicare to negotiate the price of drugs has been dominated by stories of personal suffering caused by high drug prices, accounts of lifesaving cures provided by pharmaceutical innovations, and arguments regarding nuanced economic models of how reducing drug prices could affect government spending and pharmaceutical innovation. Big questions related […]
Read MorePolicy & Sector Insights
11/30/2021
21st Annual Transamerica Retirement Survey of Workers
A Compendium of Findings About the Retirement Outlook of U.S. Workers By Catherine Collinson, Patti Rowey, Heidi Cho Transamerica Center for Retirement Studies A Compendium of Findings About the Retirement Outlook of U.S. Workers (“Compendium”), a collaboration between nonprofit Transamerica Institute® and its Transamerica Center for Retirement Studies® (TCRS), explores the health, employment, and finances […]
Read More